VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01265
Package ID: USCOURTS-cofc-1_18-vv-01265
Petitioner: William Dorris
Filed: 2018-08-21
Decided: 2020-05-13
Vaccine: influenza
Vaccination date: 2017-10-25
Condition: shoulder injuries related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 74836

AI-assisted case summary:
William Dorris filed a petition for vaccine injury compensation on August 21, 2018, alleging he suffered shoulder injuries related to vaccine administration (SIRVA) from an influenza vaccine received on October 25, 2017. The case was assigned to the Special Processing Unit. On December 27, 2019, Chief Special Master Brian H. Corcoran issued a ruling on entitlement, finding Mr. Dorris entitled to compensation. Respondent, the Secretary of Health and Human Services, accepted that the injury was a Table SIRVA injury and that the residual effects lasted more than six months, agreeing that Mr. Dorris had satisfied the legal prerequisites for compensation. The public decision does not describe the specific onset of symptoms, medical examinations, diagnostic tests, or treatments. On April 13, 2020, Respondent filed a proffer on the award of compensation, agreeing to a total award of $74,836.73. This amount was comprised of $72,500.00 for pain and suffering and $2,336.73 for unreimbursable expenses. Mr. Dorris, a competent adult, agreed with the proffered award. Chief Special Master Corcoran issued a decision on May 13, 2020, awarding Mr. Dorris the stipulated lump sum of $74,836.73. Petitioner was represented by Leah VaSahnja Durant, and Respondent was represented by Heather Lynn Pearlman. The public decision does not name any medical experts.

Theory of causation field:
Petitioner William Dorris alleged a Shoulder Injury Related to Vaccine Administration (SIRVA) following an influenza vaccine administered on October 25, 2017. Respondent accepted that the injury was a Table SIRVA injury and that the residual effects lasted more than six months, satisfying the requirements of 42 U.S.C. § 300aa-11(c)(1)(D)(i). The specific mechanism of injury and medical experts were not detailed in the public text. Chief Special Master Brian H. Corcoran issued a Ruling on Entitlement on December 27, 2019, finding Petitioner entitled to compensation. On April 13, 2020, Respondent filed a proffer on award, agreeing to a lump sum of $74,836.73, comprised of $72,500.00 for pain and suffering and $2,336.73 for unreimbursable expenses. Petitioner, represented by Leah VaSahnja Durant, agreed to the award. Respondent was represented by Heather Lynn Pearlman. Chief Special Master Corcoran issued the final decision awarding the stipulated amount on May 13, 2020.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01265-0
Date issued/filed: 2019-12-27
Pages: 4
Docket text: PUBLIC ORDER/RULING (Originally filed: 11/13/2019) regarding 24 Findings of Fact & Conclusions of Law, Signed by Chief Special Master Brian H. Corcoran. (ypb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01265-UNJ Document 28 Filed 12/27/19 Page 1 of 4
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1265V
UNPUBLISHED
Chief Special Master Corcoran
WILLIAM DORRIS,
Filed: November 13, 2019
Petitioner,
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Findings of Fact; Intramuscular
HUMAN SERVICES, Route of Administration; Influenza
(Flu) Vaccine; Shoulder Injury
Respondent. Related to Vaccine Administration
(SIRVA)
Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
petitioner.
Jeffrey T. Sprague, U.S. Department of Justice, Washington, DC, for respondent.
FINDING OF FACT1
On August 21, 2018, William Dorris filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that he suffered a left shoulder injury related to vaccine
administration (“SIRVA”) as a result of an influenza (“flu”) vaccine he received on October
25, 2017. Petition at 1. The case was assigned to the Special Processing Unit of the
Office of Special Masters.
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required
to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act
of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government
Services). This means it will be available to anyone with access to the internet. In accordance with
Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the
disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the
identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:18-vv-01265-UNJ Document 28 Filed 12/27/19 Page 2 of 4
For the reasons discussed below, I find that Petitioner’s October 25, 2017 flu
vaccine was administered intramuscularly into Petitioner’s left deltoid.
I. Relevant Procedural History
On September 5, 2018, Petitioner filed medical records as Petitioner’s Exhibits
(“Pet. Ex.”) 1-5 and a statement of completion (ECF Nos. 7-8). On October 17, 2019,
Petitioner filed an affidavit, Pet. Ex. 6 (ECF No. 9). The initial status conference was held
on October 18, 2018. Following the initial status conference, Respondent was directed
to file a status report indicating how he intended to proceed in this case (ECF No. 10).
On September 19, 2019, Respondent filed a status report stating that he had
conducted a medical review of the claim and believed that a factual ruling on the
administration of the vaccine was needed. Respondent’s Status Report, filed Sept. 19,
2019 (ECF No. 20). Respondent requested that a ruling be made prior to setting a
deadline for the Rule 4(c) report. Id.
On October 30, 2019, a telephonic status conference was held. Following the
status conference, I informed the parties that following the receipt of any additional
evidence or a status report I planned to issue a fact ruling concerning the route of
administration (ECF No. 21).
On November 6, 2019, Petitioner filed a status report (ECF No. 22). Petitioner
explained that he had attempted on numerous occasions to contact the vaccine
administrator but that it had gone bankrupt and attempts to obtain documentation from
the company and its successor were unsuccessful. Id. Thus, Petitioner confirmed that
no additional documentation exists. Id. On November 6, 2019, Petitioner also filed Exhibit
7, which Petitioner indicated is “Vaccine Recommendations and Guidelines” for Vaccine
Administration published by the Centers for Disease Controls Advisory Committee on
Immunization Practices. Id.; Pet. Ex. 7. The issue of the route of administration of
Petitioner’s October 25, 2017 flu vaccine is now ripe for resolution.
II. Medical Records
While I have reviewed the entire record, because this ruling concerns only the
route of administration of Petitioner’s October 25, 2017 flu vaccine, only evidence relevant
to this issue is summarized herein.
On October 25, 2017, Mr. Dorris received a flu vaccine. Pet. Ex. 1 at 1. The
influenza vaccination consent form lists Petitioner’s name and date of birth and indicates
that he was administered a quadrivalent vaccine. Id. The form is signed by Petitioner
and dated 10/25/17. Id. At the bottom of the form is a section marked “To be completed
by person administering vaccine.” Id. This section lists the date as 10/25/17, the lot
number and expiration date of the vaccine, and the name of the person who administered
the vaccine. Id. This section also contains the following text: “Site of Injection (Circle
One): R Deltoid / L Deltoid.” Id. “L Deltoid,” meaning left deltoid, is circled. Id.
2

Case 1:18-vv-01265-UNJ Document 28 Filed 12/27/19 Page 3 of 4
On May 9, 2018, Petitioner presented to Jaguar Therapeutics for a physical
therapy initial evaluation for pain in his left shoulder/upper arm.3 Pet. Ex. 2 at 1. In the
history of present condition/mechanism of injury section the record states, “[p]atient states
mechanism of injury was having a flu shot that was improperly given to the upper shoulder
area instead of in the lateral deltoid.” Id.
III. Petitioner’s Affidavit
Petitioner submitted an affidavit in support of his claim on October 17, 2018. Pet.
Ex. 6. In it, Petitioner avers that he received the October 25, 2017 flu vaccine at a health
fair sponsored by his employer. Id. at ¶ 1. Petitioner states, “[w]hen the vaccine
administrator gave me the shot, I complained to her that the shot was excruciatingly more
painful than any previous flu shots I had ever received, and that it was administered
unusually high up on my shoulder. She responded brusquely, saying ‘that is where the
deltoid muscle is.’ I subsequently learned that she was incorrect.” Id.
IV. Analysis
A Petitioner must prove, by a preponderance of the evidence, the factual
circumstances surrounding his claim. § 13(a)(1)(A). Under that standard, the existence
of a fact must be shown to be “more probable than its nonexistence.” In re Winship, 397
U.S. 358, 371 (1970) (Harlan, J., concurring).
In Porzio v. Sec’y of Health & Human Servs., 17-1996V, 2019 WL 5290837 (Fed.
Cl. Spec. Mstr. July 12, 2019), Respondent argued that there was insufficient evidence
that the petitioner’s vaccine was administered intramuscularly. In that case, the vaccine
administration record stated that the vaccine was injected into petitioner’s left deltoid. Id.
at *3. The prescribing information for the vaccine indicated that it was for intramuscular
use and should not be administered intravenously, intradermally, or subcutaneously. Id.
At a medical appointment, Petitioner reported that the bandage from the vaccination was
high on her arm near the bursa, consistent with the left deltoid injection site recorded on
the vaccine administration record. Id. Petitioner, a nurse practitioner, averred that she
was sitting when the vaccine was administered despite asking to stand which makes it
easier to correctly place an intramuscular injection. Id. Based on this evidence, the
special master in Porzio found that there was preponderant evidence that Petitioner had
received an intramuscular flu vaccination. Id.
In this case, like Porzio, Petitioner’s vaccine administration record indicates that
Petitioner’s vaccine was administered into his left deltoid, a muscle. Pet. Ex. 1 at 1; see,
e.g., Dorland’s Illustrated Medical Dictionary (32nd ed. 2012) at 484 (defining deltoid as
“triangular in outline, as the deltoid muscle”). Petitioner further reported to his physical
therapist that the flu shot was given in his upper shoulder area instead of his lateral, or
side, deltoid. Pet Ex. 2 at 1. Petitioner’s affidavit also indicates that the vaccine
administrator told him that the vaccine administration site was where his deltoid was. Pet.
Ex. 6 at ¶ 1. As in Porzio, these pieces of evidence all support a finding that the vaccine
was administered intramuscularly high into Petitioner’s left deltoid. And there is no
3 The record demonstrates that Petitioner also sought care for his left shoulder injury on numerous other
occasions.
3

Case 1:18-vv-01265-UNJ Document 28 Filed 12/27/19 Page 4 of 4
evidence that would suggest that Petitioner’s October 25, 2017 flu vaccine was
administered by a route other than intramuscularly, such as intradermally.
V. Conclusion
In light of the evidence indicating that the vaccine was administered
intramuscularly, and the lack of evidence supporting any other route of administration, I
find that it is more likely than not, and thus there is preponderant evidence, that
Petitioner’s October 25, 2017 flu vaccine was administered intramuscularly into his left
deltoid.
Accordingly, the following is ORDERED: Respondent shall file, by no later than
Monday, December 23, 2019, either his Rule 4(c) report or a status report indicating
how he intends to proceed in this case. At a minimum, the status report shall indicate
whether he is willing to engage in tentative discussions regarding settlement or proffer or
is opposed to negotiating at this time. In the event Respondent wishes to file a Rule 4(c)
report, he may propose a date for filing it, but shall indicate his position on entering into
negotiations regardless of whether he wishes to file a Rule 4(c) report.
IT IS SO ORDERED.
s/ Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
4

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_18-vv-01265-1
Date issued/filed: 2020-01-27
Pages: 2
Docket text: PUBLIC ORDER/RULING (Originally filed: 12/27/2019) regarding 26 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01265-UNJ Document 29 Filed 01/27/20 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1265V
UNPUBLISHED
WILLIAM DORRIS, Chief Special Master Corcoran
Petitioner, Filed: December 27, 2019
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Ruling on Entitlement; Influenza (Flu)
HUMAN SERVICES, Vaccine; Shoulder Injury Related to
Vaccine Administration (SIRVA)
Respondent.
Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
petitioner.
Jeffrey T. Sprague, U.S. Department of Justice, Washington, DC, for respondent.
RULING ON ENTITLEMENT1
On August 21, 2018, William Dorris filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered shoulder injuries related to vaccine
administration (“SIRVA”) as a result of an influenza (“flu”) vaccine he received on
October 25, 2017. Petition at 1. The case was assigned to the Special Processing Unit
of the Office of Special Masters.
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). This means the ruling will be available to anyone with access to
the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§ 300aa (2012).

Case 1:18-vv-01265-UNJ Document 29 Filed 01/27/20 Page 2 of 2
On November 13, 2019, I issued a finding of fact determining that Petitioner’s
October 25, 2017 flu vaccine was administered intramuscularly into his left deltoid.
Finding of Fact, issued Nov. 13, 2019 (ECF No. 24).
On December 23, 2019, Respondent filed his Rule 4(c) report (ECF No. 25). In
the Rule 4(c) report, Respondent states that he accepts my fact ruling as law of the
case for purposes of further proceedings. Rule 4(c) report at 6. Respondent concludes:
In light of the Chief Special Master’s fact ruling, and medical record
evidence submitted in this case, it is concluded that petitioner suffered a
Table SIRVA injury. In addition, petitioner suffered the residual effects of
his condition for more than six months. 42 U.S.C. § 300aa-11(c)(1)(D)(i).
Therefore, based on the record as it now stands and subject to his right to
appeal the Finding of Fact and Conclusions of Law, respondent does not
dispute that petitioner has satisfied all legal prerequisites for
compensation under the Act. See 42 U.S.C. § 300aa-13.
Respondent’s Rule 4(c) report at 6.
In view of Respondent’s position and the evidence of record, I find that
Petitioner is entitled to compensation.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master

================================================================================
DOCUMENT 3: USCOURTS-cofc-1_18-vv-01265-2
Date issued/filed: 2020-05-13
Pages: 4
Docket text: PUBLIC DECISION (Originally filed: 04/13/2020) regarding 35 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01265-UNJ Document 39 Filed 05/13/20 Page 1 of 4
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1265V
UNPUBLISHED
WILLIAM DORRIS, Chief Special Master Corcoran
Petitioner, Filed: April 13, 2020
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Damages Decision Based on Proffer;
HUMAN SERVICES, Influenza (Flu) Vaccine; Shoulder
Injury Related to Vaccine
Respondent. Administration (SIRVA)
Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for
petitioner.
Heather Lynn Pearlman, U.S. Department of Justice, Washington, DC, for respondent.
DECISION AWARDING DAMAGES1
On August 21, 2018, William Dorris filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that he suffered shoulder injuries related to vaccine
administration (“SIRVA”) as a result of an influenza (“flu”) vaccine he received on
October 25, 2017. Petition at 1. The case was assigned to the Special Processing Unit
of the Office of Special Masters.
On December 27, 2019, a ruling on entitlement was issued, finding Petitioner
entitled to compensation for SIRVA. On April 13, 2020, Respondent filed a proffer on
award of compensation (“Proffer”) indicating Petitioner should be awarded $74,836.73.
Proffer at 1. In the Proffer, Respondent represented that Petitioner agrees with the
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). This means the decision will be available to anyone with access
to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§ 300aa (2012).

Case 1:18-vv-01265-UNJ Document 39 Filed 05/13/20 Page 2 of 4
proffered award. Id. Based on the record as a whole, I find that Petitioner is entitled to
an award as stated in the Proffer.
Pursuant to the terms stated in the attached Proffer, I award Petitioner a lump
sum payment of $74,836.73 (comprised of $72,500.00 for pain and suffering and
$2,336.73 for unreimbursable expenses) in the form of a check payable to
Petitioner. This amount represents compensation for all damages that would be
available under § 15(a).
The clerk of the court is directed to enter judgment in accordance with this
decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:18-vv-01265-UNJ Document 39 Filed 05/13/20 Page 3 of 4
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
)
WILLIAM DORRIS, )
)
Petitioner, )
) No. 18-1265V
v. ) Chief Special Master Corcoran
) ECF
SECRETARY OF HEALTH AND HUMAN )
SERVICES, )
)
Respondent. )
)
RESPONDENT’S PROFFER ON AWARD OF COMPENSATION
On August 21, 2018, William Dorris (“petitioner”) filed a petition for vaccine injury
compensation alleging that he suffered a shoulder injury related to vaccine administration
(“SIRVA”) as result of an influenza (“flu”) vaccine administered on October 25, 2017. On
December 23, 2019, respondent conceded that entitlement to compensation was appropriate
under the terms of the Vaccine Act. On December 27, 2019, Chief Special Master Corcoran
issued a Ruling on Entitlement finding that petitioner was entitled to compensation.
I. Items of Compensation
Based upon the evidence of record, respondent proffers that petitioner should be awarded
$74,836.73, comprised of $72,500.00 for pain and suffering and $2,336.73 for unreimbursable
expenses. This amount represents all elements of compensation to which petitioner is entitled
under 42 U.S.C. § 300aa-15(a). Petitioner agrees.
II. Form of the Award
Respondent recommends that the compensation provided to petitioner be made through a
1

Case 1:18-vv-01265-UNJ Document 39 Filed 05/13/20 Page 4 of 4
lump sum payment of $74,836.73 in the form of a check payable to petitioner.1 Petitioner
agrees.
Petitioner is a competent adult. Evidence of guardianship is not required in this case.
Respectfully submitted,
JOSEPH H. HUNT
Assistant Attorney General
C. SALVATORE D’ALESSIO
Acting Director
Torts Branch, Civil Division
CATHARINE E. REEVES
Deputy Director
Torts Branch, Civil Division
ALEXIS B. BABCOCK
Assistant Director
Torts Branch, Civil Division
/s/ Heather L. Pearlman
HEATHER L. PEARLMAN
Assistant Director
Torts Branch, Civil Division
U.S. Department of Justice
P.O. Box 146
Benjamin Franklin Station
Washington, D.C. 20044-0146
Phone: (202) 353-2699
Email: heather.pearlman2@usdoj.gov
DATED: April 13, 2020
1 Should petitioner die prior to the entry of judgment, respondent reserves the right to move the
Court for appropriate relief. In particular, respondent would oppose any award for future
medical expenses, future pain and suffering, and future lost wages.
2